GC-specific HER2 scoring guidelines have been established recently, detailing that a GC biopsy specimen with complete, basolateral or lateral membranous immunoreactivity in more than five “clustered tumor cells” is classified as HER2 positive [6]. The gene discussed is ERBB2; the disease is neoplasm.